NAPNAP Daily News

The NAPNAP Daily news is available for Members Only. You will need to login as a Member to to view all of the news.

FDA Approves Deflazacort For Patients With Duchenne Muscular Dystrophy As Young As Two Years Old
FiercePharma (6/10, Sagonowsky) reports the Food and Drug Administration has approved PTC Therapeutics’ Emflaza (deflazacort) for patients with Duchenne muscular dystrophy “as young as two years old.” The drug was previously approved to treat patients who...